A healthy blood system is essential to all human life. We are investigating what constitutes a healthy blood system and diligently working on improving bone marrow and cord blood transplants. These blood products are important to all oncology programs. Blood transfusion products are required in routine cancer treatment to support chemotherapy regimens and bone marrow transplantation is the only curative procedure for eligible patients with leukemia.
To identify novel therapeutics that can target the bone marrow environment to destroy and prevent leukemia. By better understanding the optimal bone marrow conditions needed to support healthy blood stem cells, this study also has the potential to improve stem cell transplantation therapies.